Security Snapshot

HilleVax, Inc. - Common Stock (HLVX) Institutional Ownership

CUSIP: 43157M102

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

0

Shares (Excl. Options)

0

Price

$2.09

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
HLVX
Shares outstanding
49,862,069
Price per share
$2.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-42,033
Value change
-$73,977
Number of holders
0
Price from insider filings
$2.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • HLVX - HilleVax, Inc. - Common Stock is tracked under CUSIP 43157M102.
  • 0 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 0 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $0 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 0 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 43157M102?
CUSIP 43157M102 identifies HLVX - HilleVax, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Institutional Holders of HilleVax, Inc. - Common Stock (HLVX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$73,977 $2.09 0
2025 Q3 0 $0 -$82,472,877 $2.09 0
2025 Q2 41,482,960 $82,475,168 -$1,148,009 $1.99 73
2025 Q1 42,159,649 $61,462,501 -$803,616 $1.45 81
2024 Q4 42,837,211 $88,691,412 -$1,922,815 $2.07 76
2024 Q3 41,746,872 $73,514,766 -$125,350,056 $1.76 79
2024 Q2 45,490,986 $657,609,131 +$17,178,106 $14.46 91
2024 Q1 43,902,279 $730,023,644 +$27,469,011 $16.63 80
2023 Q4 42,260,488 $678,283,363 +$2,078,184 $16.05 69
2023 Q3 34,134,471 $459,257,248 +$117,952,601 $13.45 68
2023 Q2 25,405,469 $436,645,635 -$15,432,144 $17.19 54
2023 Q1 26,409,127 $436,246,966 +$31,686,995 $16.53 61
2022 Q4 26,312,441 $440,207,224 +$21,738,018 $16.73 55
2022 Q3 23,399,373 $399,913,116 -$7,528,050 $17.09 50
2022 Q2 23,224,867 $253,676,000 +$253,676,000 $10.93 54
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .